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ABSTRACT 
 
Coriandrum sativum L. (CS) seeds are known to possess therapeutic potentials against a va-
riety of physiological disorders. This study assesses acute and sub-chronic toxicity profile of 
hydro-methanolic extract of CS seeds using OECD guidelines. In acute toxicity study, mice 
were once orally administered 1000, 3000 and 5000 mg/kg body weight of CS extract. There 
were no any behavioral alterations or mortality recorded in CS treated groups. The LD50 value 
was more than 5000 mg/kg body weight. In the sub-chronic oral toxicity study, the animals 
were orally administered with CS extract (1000, 2000 and 3000 mg/kg body weight) daily for 
28 days whereas; vehicle control group received 0.5 % carboxy methyl cellulose. There was 
significant reduction in food intake, body weight gain and plasma lipid profiles of CS2 and 
CS3 (2000 and 3000 mg/kg body weight respectively) groups as compared to the control 
group. However, there were no alterations in haematological profile, relative organ weights, 
histology and plasma markers of damage of vital organs (heart, liver and kidney). The overall 
finding of this study indicates that CS extract is non-toxic up to 3000 mg/kg body weight and 
can be considered as safe for consumption. 
 
Keywords: Coriandrum sativum L., hydro-methanolic seed extract, acute toxicity,  
sub-chronic toxicity 
 
 
 
INTRODUCTION 
The traditional systems of medicine 
such as the Ayurveda, Unani and Sidda 
have been a treasure trove for development 
of majority of modern medicines. Also the 
medicinal research relies on ethnobotany 
and ethnopharmacognocy for discovery of 
new molecules for that conventionally re-
sult in drugs developments (Gurib-Fakim, 
2006). World Health Organization (WHO) 
estimates that approximately 80 % of the 
developing world’s population is using tra-
ditional medicine for primary healthcare 
(Bannerman, 1982). However, there is a 
prevalent misunderstanding that herbal 
medicines are devoid of toxic effects 
(WHO, 2004). Adverse effects of herbs 
have been reported including allergic reac-
tions, hepatotoxicity (Saad et al., 2006), 
nephrotoxicity (Colson and De Broe, 2005; 
Kwan et al., 2006; Zhu, 2002; Vanher-
weghem, 1998), cardiac toxicity (Horowitz 
et al., 1996; Moritz et al., 2005; Gaibazzi et 
al., 2002), neurotoxicity (Ernst, 2003; Ben-
jamin et al., 2001) and even death (Jensen 
and Allen, 1981) have been reported. 
Therefore, a pre-clinical toxicity study is 
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indispensible to validate their safe medi-
cinal use.  
Coriandrum sativum L. (Apiaceae) (CS) 
is an annual herb, that is widely distributed. 
Its fresh leaves and dried seeds are exten-
sively used in Middle Eastern, Mediterra-
nean, Indian, Latin American, African and 
Southeast Asian cuisines. Decoction and 
tincture of powdered seeds of CS alone or 
in combination with other herbal agents are 
recommended for dyspeptic complaints, 
loss of appetite, convulsion, insomnia and 
anxiety (Grieve, 1971). It is also used as 
medication against diabetes, indigestion, 
flatulence, renal disorders and a diuretic 
agent (Grieve, 1971; Emamghoreishi et al., 
2005). Its therapeutic potential in the treat-
ment of urethritis, cystitis, urinary tract in-
fection, urticaria, rashes, burns, sore throat, 
vomiting, indigestion, nosebleed, cough, 
allergies, hay fever, dizziness and amoebic 
dysentery has also been reported (Grieve, 
1971; PDR for Herbal Medicines, 1998). 
Phytochemical constituents of CS seeds 
have been studied extensively and their 
analysis had revealed presence of polyphe-
nols (rutin, caffeic acid derivatives, ferulic 
acid, galic acid, and chlorogenic acid), fla-
vonoids (quercetin and isoquercetin) and β-
carotenoids (Melo et al., 2003). The essen-
tial oil obtained from CS seeds contains α 
and β-pinene, camphor, citronellol, cori-
androl, p-cymene, geraniol, geranyl acetate, 
limonene, linalool, myrcene, α and β phel-
landrene and α and β-terpinene along with 
many fatty acids. Presence of water soluble 
compounds such as monoterpenoid glyco-
sides, monoterpenoid glucose sulfate and 
other glycosides have been reported (Ser-
geeva, 1975; Ishikawa et al., 2003). The 
pharmacological activities of various ex-
tracts and essential oils of CS seeds have 
been studied wherein; the essential oils 
have been found to possess antimicrobial 
(Baratta et al., 1998) and antifungal proper-
ties (Garg and Siddiqui, 1992). Its efficacy 
as a hypoglycemic (Gray and Flatt, 1999), 
hypolipidemic (Chithra and Leelamma, 
1997, 1999; Lal et al., 2004), hypocholes-
terolemic (Dhanapakiam et al., 2008), anti-
hypertensive (Medhin et al., 1986), antioxi-
dant (Melo et al., 2003; Ramadan et al., 
2003; Bajpai et al., 2005), antimutagenic 
(Cortes-Eslava et al., 2004), anxiolytic 
(Emamghoreishi et al., 2005), antimicrobial 
(Kubo et al., 2004; Cantore et al., 2004), 
larvicidal (Consoli et al., 1988) and post-
coital antifertility agent (Al-Said et al., 
1987) have also been reported. 
We had recently reported anti-insulin 
resistance (Patel et al., 2011) and cardiopro-
tective (Patel et al., 2012) potentials of CS 
seed extract. Since toxicological evaluation 
of CS seed extract is not studied, the pre-
sent study evaluates possible toxicity of CS 
seed extract using Economic Co-operation 
and Development (OECD) guidelines. 
 
MATERIAL AND METHODS 
Plant material and preparation of extract 
Seeds of CS were collected (in the 
month of February and March) and identi-
fied by Dr. P.S. Nagar, Department of 
Botany, The M.S. University of Baroda. A 
herbarium of plant was deposited in the 
Department of Botany. One hundred grams 
of powdered dry seeds were soaked in 
methanol:water (80:20 v/v) at room tem-
perature and allowed to stand for seven 
days. The resultant extract was filtered 
through a muslin cloth and then concentrat-
ed in a rotary evaporator under reduced 
pressure to obtain a thick semisolid brown 
paste (Hashim et al., 2005). The final yield 
was 8.3 g (w/w). 
 
Experimental animals 
Adult female Swiss albino mice (20-
25 g) were obtained from Zydus Cadila Re-
search Centre, Ahmedabad, Gujarat, India. 
They were housed under standard animal 
house conditions (temperature: 23 ± 2 °C; 
photoperiod: 12 h light and 12 h dark; hu-
midity: 45-50 %). They were fed with 
standard laboratory pellets (M/S Pranav 
agro, Ltd., Baroda, India) and water ad libi-
tum. The animals were maintained as per 
the guidelines of the Committee for the 
Purpose of Control and Supervision of Ex-
periments on Animals (CPCSEA) India and 
the experimental protocol approved by the 
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animal ethical committee of the Department 
of Zoology, The M. S. University of Baro-
da, Vadodara (Approval No.827/ac/04/ 
CPCSEA).  
 
Acute oral toxicity 
Acute oral toxicity study was conducted 
according to the guidelines of Organization 
for Economic Co-operation and Develop-
ment (OECD, 401). Twenty four animals 
were randomly allocated into four groups of 
six animals each. Group I (Control): ani-
mals were administered orally with vehicle 
(0.05 % Carboxy methyl cellulose; CMC). 
Remaining groups (II, III and IV) were ad-
ministered with 1000, 3000 and 5000 mg/ 
kg body weight of CS extract respectively 
via gastric intubation. Doses were prepared 
using 0.05 % CMC and dose volume was 
not more than 1 ml/kg body weight. Cage 
side observations (tremors, convulsions, 
salivation, diarrhea, lethargy, sleep and co-
ma) were recorded during first four hours 
and mortality was recorded after 24 h. 
 
Sub-chronic oral toxicity 
The sub-chronic oral toxicity study was 
conducted according to the guidelines of the 
Organization for Economic Co-operation 
and Development (OECD, 407). Twenty 
four animals were randomly divided into 
four groups of six animals each. Group I 
(CS0) served as a control and received 
0.5 % CMC (vehicle) for 28 days whereas 
the remaining groups (Group II- CS1, 
Group III- CS2 and Group IV- CS3) were 
orally administered 1000, 2000 and 
3000 mg/kg body weight respectively of CS 
extract daily for 28 consecutive days. Food 
and water intake were recorded daily, 
whereas, body weight was recorded once in 
a week throughout study period.  
 
Plasma isolation and haematology 
At the end of 28 days, blood samples 
were collected from overnight fasted ani-
mals through retro-orbital sinus puncture in 
ethylene diamine tetra acetic acid (EDTA) 
coated vials and plasma was separated by 
cold centrifugation (Plasto Crafts Super-
spin-R centrifuge) at 3000 rpm for 10 min. 
Blood was also collected for the analysis of 
haematological parameters such as white 
blood cell (WBC) count, red blood cell 
(RBC) count, haemoglobin (Hb) levels, 
mean corpuscular volume (MCV), mean 
corpuscular haemoglobin (MCH), mean 
corpuscular haemoglobin concentration 
(MCHC) and red cell distribution width 
(RCDW) using BC 2300 Haematology An-
alyzer (Shezhen Mindray Biomedical Elec-
tronics Co., Ltd., China).  
 
Plasma biochemical parameters 
Creatinine kinase-MB (cardiac dam-
age), aspartate aminotransferase (AST), al-
anine aminotransferase (ALT), bilirubin, 
total protein (liver damage) and urea and 
creatinine (kidney damage) were analyzed 
using commercially available kits (Recon 
diagnostic Ltd., Vadodara, India). Also, 
plasma glucose and lipid profile [total cho-
lesterol (TC), triglyceride (TG) and high 
density lipoprotein (HDL-C)] were assessed 
and low density lipoprotein (LDL-C) and 
very low density lipoprotein (VLDL-C) 
were calculated by Friedewald’s formula 
(Friedewald et al., 1972).  
 
Relative organ weights and histopathology 
Animals were later sacrificed by cervi-
cal dislocation under mild ether anesthesia 
for autopsy and liver, kidney, heart, lung 
and spleen were excised, rinsed in 0.9 % 
saline and weighed. After sacrifice, organ 
weights (lungs, heart, liver, kidney and 
spleen) were recorded and relative organ 
weights (ROW) were calculated as follows. 
ROW =Absolute organ weight (g) X 100 
Body weight on the day of sacrifice (g) 
Tissue pieces of vital organs (heart, liv-
er and kidneys) were fixed in 10 % para-
formaldehyde for paraffin histology and 
processed in paraffin embedding as per the 
standard protocol. 7 µm thick sections of 
each tissue were stained with hematoxylin 
and eosin, and observed for possible histo-
pathological damages. 
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RESULTS 
Acute oral toxicity 
Cage side observations did not record 
any behavioral changes such as tremor, 
convulsion, salivation, diarrhea, lethargy or 
sleep during the first four hours of CS ex-
tract (1000, 2000 or 3000 mg/kg body 
weight) administration. After 24 h there 
was no mortality recorded in plant extract 
administered groups. However, urine output 
was found to be increased in CS treated an-
imals (1000, 2000 or 3000 mg/kg body 
weight) as compared to the control (data not 
shown). 
 
Sub-chronic oral toxicity 
Body weight gain, food and water intake 
CS1 and CS2 groups did not record any 
significant alterations in body weight gain. 
However, CS3 group (3000 mg/kg body 
weight) recorded significant (p<0.001) dec-
rement in body weight gain. Further, there 
was significant (p<0.05 and p<0.001 re-
spectively) reduction in food intake of CS2 
and CS3 groups as compared to CS0. Water 
intake was significantly (p<0.05, p<0.01 
and p<0.001 respectively) increased in all 
the CS extract administered groups as com-
pared to CS0 group (Table 1).  
 
Haematology 
The haematological parameters (RBC, 
WBC, Hb, MCV, MCH, MCHC, RCDW, 
monocytes, lymphocytes, eosinophil) did 
not record any significant alterations in any 
of CS administered groups (Table 2). 
 
Biochemical parameters 
Plasma glucose recorded moderate non-
significant decrement in CS2 and CS3 
groups. Also, plasma TC, TG, LDL and 
VLDL levels recorded moderate to signifi-
cant reductions in all the CS treated groups 
but, plasma HDL levels were unaltered 
(Table 4). Plasma marker of creatinine ki-
nase-MB, AST, ALT, bilirubin, total pro-
tein, urea and creatinine did not record sig-
nificant alterations in any of the CS treated 
groups as compared to the CS0 group (Ta-
ble 3). 
 
Relative organ weights and histopathology 
There were no significant changes in 
ROW of CS treated groups as compared to 
CS0 group (Table 5). A detailed scrutiny of 
histoarchitecture of the heart, liver and kid-
ney did not reveal any observable cellular 
damage. The cellular morphology, nuclear 
characteristics and tissue integrity of organs 
of CS treated groups were comparable to 
the CS0 group (Figure 1). 
 
 
 
 
 
 
 
 
Table 1: Effect of Coriandrum sativum L. seed extract sub-chronic oral administration on food intake, 
water intake and body weight 
Groups Body weight (gm) Weight gain 
gm 
Food intake 
gm/day 
Water intake 
ml/day Initial Final 
CS0 21.78±0.76 25.10±0.70 3.32±0.25 5.22±0.21 7.47±0.83 
CS1 23.87±0.65 26.12±0.38 2.82±0.22ns 4.43±0.33ns 10.80±0.63* 
CS2 23.32±0.41 25.64±0.40 2.30±0.35* 3.78±0.39* 11.27±0.39** 
CS3 24.48±0.39* 26.24±0.34 1.68±0.23*** 3.24±0.24*** 11.46±0.56** 
where n=6. Data were expressed as mean ± S.E.M. * (p<0.05), ** (p<0.01), *** (p<0.001) and ns (not 
significant) when CS0 v/s CS1, CS2 and CS3 
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Table 2: Effect of Coriandrum sativum L. seed extract sub-chronic oral administration on haematologi-
cal parameters 
Parameter  Groups 
CS0 CS1 CS2 CS3 
RBC (x 1012/l) 8.70±0.20 8.52±0.07ns 8.72±0.29ns 8.93±0.10ns 
Hb (g/dl) 16.14±0.29 16.22±0.17ns 16.42±0.53ns 16.62±0.13ns 
MCV (fl) 44.73±0.92 44.23±0.93ns 44.17±0.73ns 42.80±0.15ns 
MCH (pg) 18.72±0.19 18.94±0.18ns 19.02±0.34ns 18.64±0.26ns 
MCHC (g/dL) 44.56±0.55 44.62±0.59ns 43.78±0.98ns 43.00±0.57ns 
RCDW ( %) 18.00±0.19 17.60±0.30ns 17.67±0.26ns 17.45±0.25ns 
WBC (x 103/µl) 16.33±0.48 16.27±0.23ns 16.43±0.83ns 16.53±0.21ns 
Monocytes ( %) 2.02±0.15 2.16±0.20ns 2.12±0.15ns 2.05±0.16ns 
Lymphocytes ( %) 7.34±0.15 7.30±0.25ns 7.18±0.24ns 7.06±0.18ns 
Eosinophils ( %) 2.34±0.23 2.10±0.43ns 1.79±0.21ns 1.88±0.27ns 
Platelet (x 103/µl) 678.60±29.43 669.40±24.14ns 667.40±20.00ns 661.20±15.83ns 
MPV (fl) 10.06±0.09 9.98±0.06ns 10.02±0.14ns 10.00±0.09ns 
RBC: Red blood corpuscle, Hb: Haemoglobin; MCV: Mean corpuscular volume, MCH: Mean corpus-
cular haemoglobin, MCHC: Mean corpuscular haemoglobin concentration, RCDW: Red cell distribu-
tion width, WBC: white blood corpuscle, MPV: Mean platelet volume, where n=6. Data were expressed 
as mean ± S.E.M. ns (not significant) when CS0 v/s CS1, CS2 and CS3 
 
 
Table 3: Effect of Coriandrum sativum L. seed extract sub-chronic oral administration on plasma 
markers of heart, liver and kidney damage 
 Groups 
 CS0 CS1 CS2 CS3 
Cardiac dam-
age markers 
Creatinine kinase-
MB (U/L) 40.60±5.42 43.72±7.40
 ns 45.27±4.88ns 40.79±4.06ns 
Hepatic dam-
age markers 
Aspartate trans- 
aminase (U/L) 29.50±2.06 26.50±2.07
ns 27.17±2.94ns 30.83±3.34ns 
Alanine trans-
aminase (U/L) 22.60±2.20 19.40±2.40
ns 21.20±1.49ns 21.60±3.23ns 
Bilirubin (mg/dl) 1.86±0.22 1.79±0.14ns 1.83±0.15ns 1.97±0.10ns 
Total protein (g/dl) 4.66±0.12 4.59±0.03ns 4.85±0.25ns 4.86±0.19ns 
Kidney dam-
age markers 
Urea (mg/dl) 58.69±6.39 58.92±4.44ns 65.45±6.92ns 62.30±6.96ns 
Creatinine (mg/dl) 0.32±0.03 0.32±0.05ns 0.36±0.04ns 0.38±0.05ns 
where n=6. Data were expressed as mean ± S.E.M. ns (not significant) when CS0 v/s CS1, CS2 and 
CS3 
 
 
Table 4: Effect of Coriandrum sativum L. seed extract sub-chronic oral administration on plasma glu-
cose, lipid profile and lipoprotein profile  
 Groups 
CS0 CS1 CS2 CS3 
Blood glucose (mg/dl) 146.20±4.97 155.7±7.06ns 139.2±5.52ns 134.2±4.71ns 
TC (mg/dl)  60.33±3.99 51.50±5.11ns 44.17±5.40ns 45.83±3.09* 
TG (mg/dl) 16.50±1.26 11.83±1.38* 11.17±1.32* 10.33±2.15* 
VLDL-C (mg/dl) 3.30±0.25 2.36±0.31* 2.23±0.23* 2.06±0.30* 
LDL-C (mg/dl) 33.21±4.57ns 25.61±5.62ns 20.52±4.24ns 20.74±3.34ns 
HDL-C (mg/dl) 23.55±1.14ns 24.03±1.03ns 23.30±0.66ns 23.03±0.78ns 
where n=6. Data were expressed as mean ± S.E.M. ns (not significant) when CS0 v/s CS1, CS2 and 
CS3 
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Table 5: Effect of Coriandrum sativum L. seed extract sub-chronic oral administration on relative  
organ weight 
Organs (gm) Groups 
 CS0 CS1 CS2 CS3 
Lungs 0.51±0.01 0.54±0.01ns 0.54±0.03ns 0.54±0.02ns 
Heart 0.42±0.01 0.43±0.01ns 0.42±0.01ns 0.40±0.01* 
Liver 3.58±0.13 3.72±0.08ns 3.61±0.11ns 3.50±0.10ns 
Kidney 1.10±0.05 1.16±0.05ns 1.12±0.02ns 1.00±0.03ns 
Spleen 0.30±0.01 0.27±0.01ns 0.29±0.02ns 0.30±0.17ns 
where, n=6. Data were expressed as mean ± S.E.M. ns (not significant) when CS0 v/s CS1, CS2 and 
CS3 
 
 
 
Figure 1: Photomicrographs of the sections of the heart (A), liver (B) and kidney (C) of control (CS0) 
and CS administered (CS1, CS2 and CS3) mice for 28 days showing no histoarchitecture change in CS 
treated groups as compared to control 
 
 
 
DISCUSSION 
Acute toxicity study recorded zero mor-
tality at the end of 24 h period, following 
CS extracts administration. No behavioral 
alterations were recorded during the first 
four hours after administration of CS ex-
tract. Hence, the LD50 of CS extract is 
thought to be greater than 5000 mg and 
therefore CS extract can be considered as 
non-toxic up to the said dose (OECD 401). 
Sub-chronic oral toxicity studies have 
provided information on drugs that can pos-
sibly pose health risks (Ministério de 
Saúde/Brasil, 2004). Twenty eight days of 
oral administration of CS (CS2 and CS3) 
extract showed significant decrement in 
food intake and body weight gain as com-
pared to CS0 mice. Significant reduction in 
food intake is suggested as responsible for 
the observed decrement in body weight 
gain. Loss of appetite is often synonymous 
with weight loss due to disturbances in car-
bohydrate, protein or fat metabolisms 
(Klaassen, 2001) and the same might be a 
possible reason for the weight loss in our 
study. CS (CS2 and CS3) treated mice also 
showed significant decrement in plasma 
TC, TG, LDL and VLDL whereas glucose 
and HDL levels were unchanged. These 
results indicate that higher doses of CS 
(CS2 and CS3) results in a reduction of food 
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intake and subsequent decrement in lipid 
profile whereas a lower dose (CS1) does not 
lead to any such negative impact on metab-
olism.  
CK-MB is an enzyme present in the 
myocardium that leaks out only under con-
ditions of massive myocardial damage re-
sulting from disintegration of contractile 
apparatus and increased sarcoplasmic per-
meability (Mair et al., 1994). Observed 
normal levels of CK-MB under all doses 
CS administration is reflective of its normal 
functional status and negligible damage. 
The same is further validated through the 
histology of heart of CS treated groups that 
reveals presence of intact myocardium. 
However, marginal increment in ROW of 
heart in CS3 group is inexplicable and war-
rants further scrutiny. 
High levels of AST and ALT are re-
ported in liver diseases or hepatotoxicity 
(Brautbar and Williams, 2002). Plasma 
AST, ALT and bilirubin of CS0 and CS 
treated groups were comparable thus in-
dicative of normal functional status of liver. 
The ROW and histopathological observa-
tions of liver showed no significant changes 
following CS treatment. 
Renal dysfunction can be assessed by 
concurrent measurements of urea and creat-
inine and their normal levels reflect at re-
duced likelihood of renal problems (Davis 
and Bredt, 1994). In the present study, 
changes in plasma urea and createnine lev-
els in CS treated groups showed non-
significant differences on a dose dependent 
manner indicating a normal renal function. 
Healthy status of the kidneys of CS treated 
groups was further confirmed by their his-
toarchitecture and ROW. However, higher 
urine output observed in CS2 and CS3 treat-
ed groups can be attributed to its diuretic 
property as reported earlier by other re-
search groups (Aissaoui et al., 2008; Jabeen 
et al., 2009). 
The haematopoietic system is one of the 
most sensitive targets for toxic compounds 
and hence it is mandatory to record any 
possible alterations resulting from a test 
substance (Olson et al., 2000). Change in 
haematological parameters has a higher 
predictive value, when the data of drug tox-
icity on animal studies are translated for 
clinical usage (Adeneye and Adokiye, 
2008). A normal haematological profile of 
CS treated groups also further justified the 
non-toxic nature of CS extract. 
 
CONCLUSION 
In light of these findings, we may con-
clude that CS extract is not toxic in all the 
doses studied herein. This study is the first 
report that evaluates toxicity of CS extract 
and defines it as non-toxic up to a dose of 
3000 mg/kg body weight. 
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